Effects of Aqualief® in Patients With Xerostomia as Consequence of Radiotherapy for Head and Neck Cancer

NCT03601962 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

100

Enrollment

INDUSTRY

Sponsor class

Stopped Low enrolment rate

Conditions

Xerostomia
Asialia
Hyposalivation
Mouth Dryness

Interventions

DIETARY_SUPPLEMENT: Aqualief
OTHER: Placebo

Sponsor

Helsinn Healthcare SA

Collaborators

[object Object]